NewAmsterdam Pharma NAMS
NASDAQ NAMS
$24.16 -0.16 (-0.66%)
At close: Oct 1, 2026 · 4:00 PM EDT

NewAmsterdam Pharma (NAMS) Tax Provisions (2024)

Updated

NewAmsterdam Pharma (NAMS) recorded Tax Provisions of -$1,000 in FY2024, compared with $27,000 in FY2023.

Analysis

NewAmsterdam Pharma (NAMS) Tax Provisions (2024) Analysis & Trends

  • Per Business Quant data, NAMS's Tax Provisions was $27,000 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.21 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 662.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 654.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -1.01 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -291.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 393.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 242.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -407.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 292.00 Mn
10 NewAmsterdam Pharma 2.86 Bn 2.86 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 -1,000.00
API Access

NewAmsterdam Pharma Tax Provisions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=tax-provisions&ticker=NAMS&period=max&api_key=YOUR_API_KEY